Explore UCD

UCD Home >
overlay image

Discovery to Application: An Innovation Journey

Innovation

UCD Conway Institute is contributing to Ireland's knowledge economy. We work in partnership with stakeholders in the education sector, the State and its agencies alongside the business and venture capital communities to develop a world-class ecosystem for innovation that drives enterprise development. Our proactive policy for the translation of research has seen many Conway Fellows establishing links with the biotechnology and pharmaceutical sectors through collaborative programmes, contract research and campus companies. 

Incubation Facilities

Begin your entrepreneurial journey in dedicated bioincubation space at UCD Conway Institute, Ireland's premier biosciences research institute. We can provide a range of flexible occupancy options to suit your research needs.

24/7 access
research laboratory space (options range from 30 - 600sqm)
desk space
wireless network
boardroom and meeting facilities
café with external deck and garden
UCD campus facilities including bank, sports & leisure centre, restaurant

Contact: (opens in a new window)Emer Bonham, Institute Operations Manager

Contract Research

At UCD Conway, companies can partner with our expert scientists on research & development projects to gain new insights or answer particular research questions or leverage our technological expertise across a wide range of experimental platforms. We have a track record in successful partnerships with Irish and international industry partners. We can deliver comprehensive solutions to challenging research questions for our academic and industrial partners.

 

 

Man working in laboratory
Collaborative Research

Conway Fellows have successful collaborations with scientists worldwide. These collaborations have led to publications in academic journals with scientists from more 1500 organisations in more than 70 countries worldwide. 

Find an expert by clicking on the arrow below.

Woman working in laboratory
(opens in a new window)
Supporting Industry Partnerships

There is expertise available within both the institute and wider university to support the process of partnering with industry. From the initial scope of the project and scheduling through to the methods of knowledge transfer, an academic-industry partnership can flourish with the expertise in NovaUCD, based within the Office of the Vice President for Research, Innovation & Impact.  

 

Inside building with atrium garden
(opens in a new window)
Supporting Technology Transfer

Working closely with NovaUCD, UCD Conway Institute ensures our researchers have access to support services including technology development grants, practical business advice, continuing professional education in the area of intellectual property management, and incubation facilities to assist in the establishment and development of campus companies. Current clients include:

  • Atturos 
  • ATXA Therapeutics 
  • MetHealth
Gloved hand holding tube

Innovation Spotlights

ACR Awards Accelerating Research to Commercialisation (ARC) Hub for Therapeutics awarded €31.6M
Led by Prof. William Gallagher, the ARC Hub will accelerate translational research in small molecule therapies, biological therapies, biomaterials, biomarkers with therapeutic potential and in advanced therapy medicinal products.
Women smiling with award EpiCapture named 2024 NovaUCD Spin-out of the Year
Prof. Antoinette Perry recognised for developing accurate and non-invasive liquid tests for the early detection and prognostic assessment of high-grade cancers, including prostate cancer.
Women smiling with award plaque 2024 NovaUCD Innovation Award for ATXA Therapeutics Founder
Prof. Therese Kinsella is recognised for excellence in innovation and successes achieved in commercialising life-changing treatments for cardiopulmonary diseases.
Graphic showing process of cancer cells moving in the body Taking control of cancer by metastasis prevention
Targeting the factors that control the movement of cancer cells from the primary site provides a new opportunity to specifically block cancer metastasis.
(opens in a new window)
Pink ribbon for breast cancer OncoMark: avoiding unnecessary chemotherapy in breast cancer patients
OncoMasTR is a patented technology to reliably predict metastatic spread in breast cancer patients. It is exclusively licensed into a UCD spin-out company, OncoMark founded by co-inventors including Prof. William Gallagher.
(opens in a new window)
Pills on blue background No more needles: developing oral peptide treatments for diabetes
Prof. Brayden, working with an industry partner, developed a new nanoparticle to allow diabetes patients take insulin and other peptides orally, rather than with an injection.

UCD Conway Institute of Biomolecular and Biomedical Research

University College Dublin, Belfield, Dublin 4, Ireland.
T: +353 1 716 6700 | E: conway@ucd.ie